Search Results 311-320 of 17175 for egfr
... (eGFR) \<30 mL/min/1.73m\^2 * Liver failure * Uncontrolled blood pressure * Unable or unwilling to take vitamin A supplementation for the duration of the ...
* Known actionable genomic alterations (EGFR, ALK, ROS1, and BRAF V600E) or genes for which first-line approved therapies are available. * For non-squamous ...
Erlotinib (Tarceva) is a human EGFR type 1 tyrosine kinase inhibitor and offers greater survival benefit to EGFR positive patients. This study will assist ...
* eGFR ≥ 30 mL/min/1.73 m2 * Must be vaccinated for S pneumoniae prior to randomization * Must be vaccinated for H influenzae type B (where available) ...
eGFR < 30 mL/min/1.73 m2, serum creatinine > 2.5 mg/dL or requiring dialysis; Known permanent or current atrial fibrillation (history of paroxysmal atrial ...
... (eGFR ≥ 60ml/min). Study Of 225Ac-ABD147 To Establish Optimal Dose In Patients With SCLC And LCNEC Of The Lung That Previously Received Platinum-based ...
... eGFR and proteinuria (P<0.001). Subclinical ABMR was associated with more rapid progression to transplant glomerulopathy. Of patients with subclinical TCMR ...
Nephrocalcinosis, reduced creatinine clearance or eGFR < 60 mL/min; Hypercalciuria or other biochemical indices of renal stone risk or both; Persistently ...
... EGFR Amplification Leading to Successful Treatment With Erlotinib. Clin Genitourin Cancer. 2017 Aug; 15 (4):e727-e734 Epub 2016 Dec 01. View PubMed; Reinholz ...
Kidney function must be at a certain level (eGFR of at least 30 ml/min/1.73 m²). 8. Specific scores related to kidney biopsy results must be within certain ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.